Hydrolase protein
It is an object of the present invention to provide a novel hydrolase, which is used when dialkyl 2-vinylcyclopropane-1,1-dicarboxylate is hydrolyzed with an enzyme, so as to efficiently obtain (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid that is useful as an intermediate for synthesizing therapeutic agents for hepatitis C. According to the present invention, there is provided a hydrolase protein, which consists of the amino acid sequence shown in any one of SEQ ID NOS. 2 to 5 and which has activity of catalyzing, at higher selectivity than the protein consisting of the amino acid sequence shown in SEQ ID NO. 1, a reaction of producing (1S,2S)-1-ethoxycarbonyl-2-vinylcyclopropanecarboxylic acid from diethyl 2-vinylcyclopropane-1,1-dicarboxylate.
1. A hydrolase protein capable of catalyzing the following reaction at higher selectivity than the protein consisting of the amino acid sequence shown in SEQ ID NO: 1:
which hydrolase protein comprises an amino acid sequence having 90% or more identity to SEQ ID NO: 2, and wherein one or more amino acids of the amino acid sequence are substituted at positions corresponding to one or more of amino acid residue numbers 70, 270, and 273 with other amino acids whose side chains are less bulky than those of wild-type amino acids.
2. The hydrolase protein of claim 1 , wherein at least the leucine at amino acid residue number 70 of any one of SEQ ID NOS: 1 to 5 is substituted with aspartic acid, asparagine, serine, threonine, or glycine.
3. The hydrolase protein of claim 1 , wherein at least the leucine at amino acid residue number 270 of SEQ ID NO: 3 or 4 is substituted with any one of serine, glutamine, glutamic acid, or alanine.
4. The hydrolase protein of claim 1 , wherein at least the isoleucine at amino acid residue number 270 of any one of SEQ ID NOS: 1, 2, and 5, is substituted with any one of serine, glutamine, glutamic acid, or alanine.
5. The hydrolase protein of claim 1 , wherein at least the leucine at amino acid residue number 273 in any one of SEQ ID NOS: 1 to 5 is substituted with either arginine or histidine.
6. The hydrolase protein of claim 1 , wherein the parent hydrolase is selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 4, and SEQ ID NO: 5.
7. An expression vector comprising a nucleic acid sequence encoding the hydrolase of claim 1 .
8. A hydrolase protein which consists of an amino acid sequence having 90% or more identity with the amino acid sequence of SEQ ID NO: 2, and wherein, one or more amino acids corresponding to amino acid residue numbers 70, 270, and 273 are substituted with other amino acids whose side chains have less bulkiness than those of wild-type amino acids.
9. An expression vector comprising a nucleic acid sequence encoding the hydrolase of claim 8 .
10. A method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid, which comprises contacting dialkyl 2-vinylcyclopropane-1,1-dicarboxylate with a hydrolase protein to produce (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid, wherein the hydrolase protein
is capable of catalyzing the following reaction at higher selectivity than the protein consisting of the amino acid sequence shown in SEQ ID NO: 1:
comprises an amino acid sequence having 90% or more identity to SEQ ID NO: 2, and wherein one or more amino acids of the hydrolase protein are substituted at positions corresponding to one or more of amino acid residue numbers 70, 270, 273, and 313 with other amino acids whose side chains are less bulky than those of wild-type amino acids.
11. A method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid, which comprises contacting dialkyl 2-vinylcyclopropane-1,1-dicarboxylate with a hydrolase protein to produce (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropanecarboxylic acid,
wherein the hydrolase protein consists of an amino acid sequence having 90% or more identity with the amino acid sequence of SEQ ID NO: 2, and wherein, one or more amino acids corresponding to amino acid residue numbers 70, 270, 273, and 313 are substituted with other amino acids whose side chains have less bulkiness than those of wild-type amino acids.